Europe’s quantum ambitions are beginning to acquire the industrial machinery needed between laboratory research and commercial hardware, with a new Copenhagen facility designed to manufacture quantum chips rather than simply demonstrate experimental devices.

Quantum Foundry Copenhagen plans to establish a 5,300-square-metre fabrication facility in the Danish capital, with opening scheduled for 2027. Owned by the Novo Nordisk Foundation, the company develops manufacturing tools, materials, and processes intended for next-generation quantum processors.

The planned site will combine nanofabrication with advanced characterisation and testing, chip assembly and packaging, and ultra-high-vacuum manufacturing. It will also offer wafer fabrication to quantum technology vendors on commercial terms, making the operation closer to a specialist manufacturing platform than an academic cleanroom serving a single research programme.

Quantum computing still contains several competing hardware approaches, and no processor architecture has established the industrial dominance seen in conventional computing. Yet any approach that progresses beyond small experimental devices encounters a similar manufacturing constraint: proving a component in a laboratory is different from making it repeatedly, at sufficient quality, for other organisations to depend on it.

Research strength meets a manufacturing constraint

Quantum Foundry Copenhagen is focusing on bottom-up manufacturing using ultra-high-vacuum techniques, with an emphasis on atomic and isotopic purity and close control of materials. Its work spans superconducting, semiconducting, and photonic components, exposing the facility to several of the architectures being pursued across the quantum market.

That breadth reflects the state of the supply chain. Conventional semiconductor companies can draw on decades of specialised foundries, packaging businesses, equipment suppliers, and design tooling, which means a chip designer does not need to own every stage of production. Quantum hardware remains much more vertically integrated, and individual developers can find themselves solving material and fabrication problems before they can test the computing system they ultimately want to sell.

A shared specialist foundry could remove some of that duplication, although the commercial challenge will be keeping processes precise enough for customers whose requirements vary substantially. Quantum devices can be unusually sensitive to defects, contamination, and material variation, so repeatability will matter as much as adding production space.

The Novo Nordisk Foundation has committed more than DKK2.9 billion, or about €390 million, to quantum technology, including its Quantum Computing Programme at the Niels Bohr Institute. That programme is targeting a fully functional fault-tolerant quantum computer before 2034, while the foundry is intended to connect research investment with manufacturing infrastructure available to a wider market.

Manufacturing joins Europe’s sovereignty agenda

The facility also sits inside a broader European attempt to retain more of the value created by strategically important technologies. The EU’s Quantum Europe Strategy, the Chips Act, and plans for a future Quantum Act all reflect concern that strong scientific research does not automatically produce competitive manufacturing companies.

Semiconductors provide a useful precedent. Europe retains significant strengths in equipment, automotive chips, power electronics, and research, yet much leading-edge fabrication capacity is concentrated elsewhere. Quantum computing remains early enough for manufacturing geography to be less settled, giving European projects an opportunity to establish industrial capacity before mature global supply chains emerge.

Building a facility, however, does not create a market by itself. The foundry will need customers with designs worth manufacturing, engineers capable of operating specialised processes, dependable supplies of high-purity materials, maintained equipment, and enough utilisation to support continuing investment.

Commercial access could therefore prove more consequential than the size of the building. Developers able to move promising devices from university or company laboratories into repeatable wafer fabrication without constructing their own production lines can concentrate capital on processors, control systems, software, and applications instead.

The Copenhagen project does not resolve which quantum architecture will win or how quickly the technology will reach economically useful performance. It addresses a nearer industrial requirement: quantum devices have to be produced with repeatable manufacturing discipline if the sector is to move beyond bespoke experiments. The 2027 opening will provide an early test of whether Europe’s growing quantum-company base can generate enough demand to support that specialist manufacturing layer.